Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,007 | 120 | 94.1% |
| Consulting Fee | $125.00 | 1 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $990.52 | 61 | $0 (2024) |
| Indivior Inc. | $190.27 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $147.39 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $143.10 | 7 | $0 (2024) |
| Alkermes, Inc. | $136.98 | 7 | $0 (2024) |
| Corium, LLC | $98.36 | 5 | $0 (2024) |
| Braeburn Inc. | $88.02 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $86.31 | 5 | $0 (2024) |
| ITI, Inc. | $79.72 | 5 | $0 (2023) |
| Axsome Therapeutics, Inc. | $45.18 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $862.22 | 52 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($147.39) |
| 2023 | $262.58 | 14 | ITI, Inc. ($79.72) |
| 2022 | $40.40 | 2 | Indivior Inc. ($23.40) |
| 2019 | $101.57 | 7 | Janssen Pharmaceuticals, Inc ($89.99) |
| 2018 | $323.64 | 22 | Janssen Pharmaceuticals, Inc ($323.64) |
| 2017 | $541.87 | 24 | Janssen Pharmaceuticals, Inc ($401.62) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $0.80 | General |
| Category: Neuroscience | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Opioid Use Disorder | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Neuroscience | ||||||
| 10/23/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Opioid Use Disorder | ||||||
| 10/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: CNS | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Neuropsychiatry | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neuroscience | ||||||
| 08/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Psychology/Psychiatric | ||||||
| 07/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 12 | 32 | $3,606 | $2,083 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 32 | $3,606 | $2,083 | 57.8% |
About Dr. Ralph Berry, MD
Dr. Ralph Berry, MD is a Psychiatry healthcare provider based in Glens Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972591097.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Berry, MD has received a total of $2,132 in payments from pharmaceutical and medical device companies, with $862.22 received in 2024. These payments were reported across 121 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,007).
As a Medicare-enrolled provider, Berry has provided services to 12 Medicare beneficiaries, totaling 32 services with total Medicare billing of $2,083. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Glens Falls, NY
- Active Since 10/12/2005
- Last Updated 06/15/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1972591097
Products in Payments
- INVEGA SUSTENNA (Drug) $800.04
- CAPLYTA (Drug) $227.11
- SPRAVATO (Drug) $134.34
- SUBOXONE SUBLINGUAL FILM (Drug) $125.00
- Azstarys (Drug) $98.36
- BRIXADI (Drug) $88.02
- INGREZZA (Drug) $86.31
- ABILIFY MAINTENA (Drug) $80.28
- VIVITROL (Drug) $64.03
- INVEGA TRINZA (Drug) $56.14
- REXULTI (Drug) $55.55
- LYBALVI (Drug) $45.31
- Auvelity (Drug) $45.18
- SUBLOCADE (Drug) $43.44
- ABILIFY ASIMTUFII (Drug) $40.11
- VRAYLAR (Drug) $31.89
- UZEDY (Drug) $31.58
- ARISTADA (Drug) $27.64
- PERSERIS (Drug) $21.83
- FANAPT (Drug) $18.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Glens Falls
April Beasley-Irving, M.d, M.D
Psychiatry — Payments: $8,238
Alexandr Glozman, Md, MD
Psychiatry — Payments: $3,693
Dr. Behrooz Ebrahimi-Fard, Md, MD
Psychiatry — Payments: $1,955
Harry Mahood, Md, MD
Psychiatry — Payments: $1,482
Dr. Abdul Brula, Md, MD
Psychiatry — Payments: $1,464
Dr. Muhammad Munawar, M.d, M.D
Psychiatry — Payments: $410.25